TRESSA COCHRAN: Open Payments
NPI 1124095740 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,558 in 77 payments from 17 companies in 2025. Trend: 2023 $1,848 · 2024 $1,638 · 2025 $1,558
Food & beverage: $1,558
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $336 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $278 |
| AstraZeneca Pharmaceuticals LP | 10 | $247 |
| Novo Nordisk Inc | 6 | $214 |
| Amgen Inc. | 12 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
| Lilly USA, LLC | 3 | $48 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| PFIZER INC. | 2 | $29 |
Products named: Ozempic, AIRSUPRA, UBRELVY, OTEZLA, QULIPTA, Kerendia, FARXIGA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
